Application of cr-wpi in the treatment of erectile dysfunction
Patent Information
- Authority / Receiving Office
- CN ¡ China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY
- Publication Date
- 2022-04-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the application of CR-WPI in treating erectile dysfunction, and belongs to the field of biomedicine. Background technique
[0002] The incidence of erectile dysfunction (ED) is high, and the incidence rate is as high as 50% in men over 40 years old. Among them, patients with severe erectile dysfunction do not respond well to traditional PDE5 inhibitors. Diabetes mellitus (DM) is one of the most common risk factors for severe erectile dysfunction, and patients with diabetic erectile dysfunction (DMED) have a certain tolerance to PDE-5 inhibitors, the current first-line drugs for the treatment of erectile dysfunction. Accumulating evidence indicates that oxidative stress plays an important role in the formation and progression of DMED. Studies have shown that antioxidants can reduce the production of ROS and improve endothelial function in diabetes-related ED, indicating that antioxidant therapy plays an important role in improv...